{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Is The Cigna Group technically bullish or bearish?
As of October 31, 2025, The Cigna Group's technical trend is bearish with weak strength indicators, underperforming the S&P 500 by -18.28% over the past year compared to its 19.89% gain.
Is The Cigna Group technically bullish or bearish?
As of October 31, 2025, The Cigna Group's technical trend is bearish, supported by negative indicators like bearish MACD readings and underperformance against the S&P 500, with a 1-year return of -22.36%.
Is The Cigna Group technically bullish or bearish?
As of October 31, 2025, The Cigna Group's technical trend is bearish, supported by negative MACD signals and underperformance against the S&P 500, with a year-to-date return of -11.49% compared to the S&P's 16.30%.
Cigna Group Stock Hits Day Low of $245.70 Amid Price Pressure
The Cigna Group's stock has faced notable volatility, hitting an intraday low and experiencing significant declines over various time frames. Despite these challenges, the company demonstrates strong long-term fundamentals, including a solid Return on Equity and high institutional ownership, while maintaining a premium valuation in the healthcare sector.
Cigna Group Faces Weak Start with 12% Gap Down Amid Market Concerns
The Cigna Group experienced a significant stock decline today, reflecting a broader trend of underperformance over the past month. Despite this, the company maintains a strong market capitalization and solid financial metrics, including a notable dividend yield and a healthy return on equity.
Cigna Group Hits New 52-Week Low at $245.70 Amid Declining Stock Performance
Cigna Group has hit a new 52-week low, reflecting a challenging year with a significant stock decline. Despite this, the company retains a substantial market capitalization and strong long-term fundamentals, including impressive net profit growth and a high dividend yield, though it has underperformed compared to the S&P 500.
Cigna Group Stock Hits Day Low Amid Price Pressure, Drops to $298.68
The Cigna Group's stock declined today, contrasting with a slight gain in the S&P 500. Despite recent challenges, the company reported strong long-term fundamentals, including a significant increase in net profit for the first half of the year and high institutional holdings, though it has underperformed against the S&P 500 over the past three years.
Cigna Group Experiences Revision in Stock Evaluation Amid Market Dynamics
Cigna Group has revised its evaluation amid changing market conditions, with its stock currently priced at $302.99. Over the past year, Cigna has seen an 11.33% decline, contrasting with the S&P 500's gains. Recent performance metrics indicate mixed results, highlighting challenges in maintaining momentum.
Is The Cigna Group technically bullish or bearish?
As of October 3, 2025, The Cigna Group's trend is mildly bearish, with mixed performance indicators showing a recent 5.70% weekly outperformance against the S&P 500, but underperformance over the past month, year-to-date, and year.
Cigna Group Hits Day High with Strong 4.72% Intraday Surge
The Cigna Group has seen significant gains today, reaching an intraday high and showing strong weekly and monthly performance. Despite a challenging year, the company has demonstrated resilience with notable year-to-date growth and impressive fundamentals, including a high return on equity and substantial net profit growth. Its market capitalization is approximately USD 90.99 billion.
Is The Cigna Group technically bullish or bearish?
As of October 3, 2025, The Cigna Group's technical trend is mildly bearish overall, with mixed indicators showing short-term outperformance but long-term underperformance compared to the S&P 500.
Is The Cigna Group technically bullish or bearish?
As of October 3, 2025, The Cigna Group's trend is mildly bearish, with mixed technical indicators and a year-to-date return of 12.62%, underperforming the S&P 500's 14.18%.
Is The Cigna Group technically bullish or bearish?
As of September 4, 2025, The Cigna Group's trend is mildly bearish, with mixed technical indicators and underperformance compared to the S&P 500, showing a 1-year return of -17.34% versus 17.14% for the index.
Is The Cigna Group overvalued or undervalued?
As of July 7, 2025, The Cigna Group is considered overvalued due to a high P/E ratio of 16 compared to peers, an elevated EV to EBITDA ratio of 33.02, and poor performance with a 1-year return of -17.34% versus the S&P 500's 17.14%.
Is The Cigna Group overvalued or undervalued?
As of October 15, 2023, Cigna Group is considered attractive and undervalued with a price-to-earnings ratio of 12.5, compared to higher ratios of its peers, indicating potential upside for investors.
Is The Cigna Group technically bullish or bearish?
As of October 1, 2023, there is insufficient technical data for The Cigna Group to determine if it is bullish or bearish.
Who are in the management team of The Cigna Group?
As of March 2022, The Cigna Group's management team includes Mr. Isaiah Harris (Independent Chairman), Mr. David Cordani (CEO), and several independent directors: Ms. Kimberly Ross, Mr. William DeLaney, Mr. Eric Foss, Maj. Gen. Elder Granger, and Ms. Kathleen Mazzarella. They oversee the company's strategic direction and operations.
What does The Cigna Group do?
The Cigna Group is a large-cap health services company specializing in healthcare services, with a recent net profit of $1.41 billion and a market capitalization of approximately $94.58 billion. Key metrics include a P/E ratio of 16.00 and a return on equity of 14.33%.
How big is The Cigna Group?
As of Jun 18, The Cigna Group has a market capitalization of $94.58 billion, with net profit of $5.40 billion and total assets of $151.50 billion.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
